{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:39:27Z","timestamp":1760834367785,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jocn.2019.03.028","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T09:10:34Z","timestamp":1553159434000},"page":"33-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Late recurrence of medulloblastoma after 17\u202fyears of complete remission"],"prefix":"10.1016","volume":"64","author":[{"given":"Antonio Jose","family":"Vargas L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Sola Vendrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Fern\u00e1ndez Carballal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2019.03.028_b0005","first-page":"15","article-title":"Brain tumors in children","volume":"1","author":"Laurent","year":"1985","journal-title":"J Paediatr Neurosci"},{"key":"10.1016\/j.jocn.2019.03.028_b0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/neuonc\/nos267","article-title":"Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children\u2019s Oncology Group trial A9961","volume":"15","author":"Ne Packer","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2019.03.028_b0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0031-3955(16)34829-5","article-title":"Childhood brain tumors: current status of clinical trials in newly diagnosed and recurrent disease","volume":"32","author":"Allen","year":"1985","journal-title":"Pediatr Clin N Am"},{"key":"10.1016\/j.jocn.2019.03.028_b0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3171\/jns.1991.75.4.0575","article-title":"Medulloblastoma: freedom from relapse longer than 8 years \u2013 a therapeutic cure?","volume":"75","author":"Belza","year":"1991","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2019.03.028_b0025","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/pbc.22382","article-title":"Second complete remission of relapsed medulloblastoma induced by metronomic chemotherapy","volume":"54","author":"Sterba","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jocn.2019.03.028_b0030","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1002\/cncr.28907","article-title":"Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity?","volume":"120","author":"Wetmore","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2019.03.028_b0035","first-page":"474","article-title":"Wilm\u2019s tumor: its behavior and prognosis","volume":"107","author":"Collins","year":"1955","journal-title":"J La State Med Soc"},{"key":"10.1016\/j.jocn.2019.03.028_b0040","first-page":"988","article-title":"Observations on growth rates of human tumors","volume":"76","author":"Collins","year":"1956","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jocn.2019.03.028_b0045","first-page":"107","article-title":"Medulloblastoma: children who have survived beyond the risk period of Collins","volume":"19","author":"Nishio","year":"1994","journal-title":"Nerv Syst Child"},{"key":"10.1016\/j.jocn.2019.03.028_b0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1097-0142(19850101)55:1<186::AID-CNCR2820550129>3.0.CO;2-X","article-title":"Medulloblastoma. Period of risk reviewed","volume":"55","author":"Latchaw","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2019.03.028_b0055","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/1097-0142(19880815)62:4<826::AID-CNCR2820620431>3.0.CO;2-M","article-title":"Late recurrence of primitive neuroectodermal tumor\/medulloblastoma","volume":"62","author":"Lefkowitz","year":"1988","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jocn.2019.03.028_b0060","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s003810050444","article-title":"Recurrence of medulloblastoma 19 years after the initial diagnosis","volume":"15","author":"Amagasaki","year":"1999","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jocn.2019.03.028_b0065","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/bjc.1998.220","article-title":"Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?","volume":"77","author":"Bouffet","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jocn.2019.03.028_b0070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11060-014-1598-8","article-title":"Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial","volume":"120","author":"Bode","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2019.03.028_b0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ccell.2014.11.002","article-title":"Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease","volume":"27","author":"Hill","year":"2015","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jocn.2019.03.028_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-013-1206-3","article-title":"Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations","volume":"115","author":"Kostaras","year":"2013","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.jocn.2019.03.028_b0085","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00381-012-2013-4","article-title":"Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience","volume":"29","author":"Aguilera","year":"2013","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"10.1016\/j.jocn.2019.03.028_b0090","first-page":"49","article-title":"Very late relapse of medulloblastoma","volume":"42","author":"Cie\u015blak","year":"2004","journal-title":"Folia Neuropathol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819302358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819302358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:19:23Z","timestamp":1760822363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586819302358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":18,"alternative-id":["S0967586819302358"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2019.03.028","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late recurrence of medulloblastoma after 17\u202fyears of complete remission","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2019.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}